APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dog Pharmaceuticals and Supplements

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dog Pharmaceuticals and Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

6 June 2026191 pages

Choose your research edition.

Industry ResearchDog Pharmaceuticals and Supplements Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Dog Pharmaceuticals and Supplements Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Dog Pharmaceuticals and Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dog Pharmaceuticals and Supplements Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Dog Pharmaceuticals and Supplements Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Dog Pharmaceuticals and Supplements market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Dog Pharmaceuticals and Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dog Pharmaceuticals and Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dog Pharmaceuticals and Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dog Pharmaceuticals and Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dog Pharmaceuticals and Supplements include Virbac, Zoetis, Vetoquinol, Nestle Purina, NOW Foods, Nutramax Laboratories, Bayer, Foodscience corporation and Manna Pro Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dog Pharmaceuticals and Supplements market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dog Pharmaceuticals and Supplements and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dog Pharmaceuticals and Supplements sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dog Pharmaceuticals and Supplements market size, projected growth trends, production technologies, key applications, and end-use industries.

Dog Pharmaceuticals and Supplements Segment by Company

Virbac

Zoetis

Vetoquinol

Nestle Purina

NOW Foods

Nutramax Laboratories

Bayer

Foodscience corporation

Manna Pro Products

Ark Naturals

Blackmores

Zesty Paws

Nuvetlabs

Mavlab

Vetafarm

Nupro Supplements

Dog Pharmaceuticals and Supplements Segment by Type

Pharmaceuticals

Supplements

Dog Pharmaceuticals and Supplements Segment by Application

Puppy

Adult Dogs

Dog Pharmaceuticals and Supplements Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dog Pharmaceuticals and Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dog Pharmaceuticals and Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dog Pharmaceuticals and Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dog Pharmaceuticals and Supplements market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dog Pharmaceuticals and Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Dog Pharmaceuticals and Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Dog Pharmaceuticals and Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Dog Pharmaceuticals and Supplements Industry Trends Table 2. Dog Pharmaceuticals and Supplements Industry Drivers Table 3. Dog Pharmaceuticals and Supplements Industry Opportunities and Challenges Table 4. Dog Pharmaceuticals and Supplements Industry Restraints Table 5. Global Dog Pharmaceuticals and Supplements Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Dog Pharmaceuticals and Supplements Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Dog Pharmaceuticals and Supplements Sales Market Share by Manufacturers Table 9. Global Dog Pharmaceuticals and Supplements Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Dog Pharmaceuticals and Supplements Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Dog Pharmaceuticals and Supplements Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Dog Pharmaceuticals and Supplements Manufacturers, Product Type & Application Table 13. Global Dog Pharmaceuticals and Supplements Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Dog Pharmaceuticals and Supplements by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Pharmaceuticals Table 17. Major Manufacturers of Supplements Table 18. Global Dog Pharmaceuticals and Supplements Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Dog Pharmaceuticals and Supplements Sales by Type (2021-2026) & (k units) Table 20. Global Dog Pharmaceuticals and Supplements Sales by Type (2027-2032) & (k units) Table 21. Global Dog Pharmaceuticals and Supplements Sales Market Share by Type (2021-2026) Table 22. Global Dog Pharmaceuticals and Supplements Sales Market Share by Type (2027-2032) Table 23. Global Dog Pharmaceuticals and Supplements Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Dog Pharmaceuticals and Supplements Revenue by Type (2021-2026) & (k units) Table 25. Global Dog Pharmaceuticals and Supplements Revenue by Type (2027-2032) & (k units) Table 26. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Type (2021-2026) Table 27. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Puppy Table 29. Major Manufacturers of Adult Dogs Table 30. Global Dog Pharmaceuticals and Supplements Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Dog Pharmaceuticals and Supplements Sales by Application (2021-2026) & (k units) Table 32. Global Dog Pharmaceuticals and Supplements Sales by Application (2027-2032) & (k units) Table 33. Global Dog Pharmaceuticals and Supplements Sales Market Share by Application (2021-2026) Table 34. Global Dog Pharmaceuticals and Supplements Sales Market Share by Application (2027-2032) Table 35. Global Dog Pharmaceuticals and Supplements Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Dog Pharmaceuticals and Supplements Revenue by Application (2021-2026) & (k units) Table 37. Global Dog Pharmaceuticals and Supplements Revenue by Application (2027-2032) & (k units) Table 38. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Application (2021-2026) Table 39. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Application (2027-2032) Table 40. Global Dog Pharmaceuticals and Supplements Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Dog Pharmaceuticals and Supplements Sales by Region (2021-2026) & (k units) Table 42. Global Dog Pharmaceuticals and Supplements Sales Market Share by Region (2021-2026) Table 43. Global Dog Pharmaceuticals and Supplements Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Dog Pharmaceuticals and Supplements Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Dog Pharmaceuticals and Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Dog Pharmaceuticals and Supplements Sales by Country (2021-2026) & (k units) Table 47. North America Dog Pharmaceuticals and Supplements Sales by Country (2027-2032) & (k units) Table 48. Europe Dog Pharmaceuticals and Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Dog Pharmaceuticals and Supplements Sales by Country (2021-2026) & (k units) Table 50. Europe Dog Pharmaceuticals and Supplements Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Dog Pharmaceuticals and Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Dog Pharmaceuticals and Supplements Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Dog Pharmaceuticals and Supplements Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Dog Pharmaceuticals and Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Dog Pharmaceuticals and Supplements Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Dog Pharmaceuticals and Supplements Sales by Country (2027-2032) & (k units) Table 57. Global Dog Pharmaceuticals and Supplements Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Dog Pharmaceuticals and Supplements Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Dog Pharmaceuticals and Supplements Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Region (2021-2026) Table 61. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Region (2027-2032) Table 62. Virbac Company Information Table 63. Virbac Business Overview Table 64. Virbac Dog Pharmaceuticals and Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Virbac Dog Pharmaceuticals and Supplements Product Portfolio Table 66. Virbac Recent Development Table 67. Zoetis Company Information Table 68. Zoetis Business Overview Table 69. Zoetis Dog Pharmaceuticals and Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Zoetis Dog Pharmaceuticals and Supplements Product Portfolio Table 71. Zoetis Recent Development Table 72. Vetoquinol Company Information Table 73. Vetoquinol Business Overview Table 74. Vetoquinol Dog Pharmaceuticals and Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Vetoquinol Dog Pharmaceuticals and Supplements Product Portfolio Table 76. Vetoquinol Recent Development Table 77. Nestle Purina Company Information Table 78. Nestle Purina Business Overview Table 79. Nestle Purina Dog Pharmaceuticals and Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Nestle Purina Dog Pharmaceuticals and Supplements Product Portfolio Table 81. Nestle Purina Recent Development Table 82. NOW Foods Company Information Table 83. NOW Foods Business Overview Table 84. NOW Foods Dog Pharmaceuticals and Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. NOW Foods Dog Pharmaceuticals and Supplements Product Portfolio Table 86. NOW Foods Recent Development Table 87. Nutramax Laboratories Company Information Table 88. Nutramax Laboratories Business Overview Table 89. Nutramax Laboratories Dog Pharmaceuticals and Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Nutramax Laboratories Dog Pharmaceuticals and Supplements Product Portfolio Table 91. Nutramax Laboratories Recent Development Table 92. Bayer Company Information Table 93. Bayer Business Overview Table 94. Bayer Dog Pharmaceuticals and Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Bayer Dog Pharmaceuticals and Supplements Product Portfolio Table 96. Bayer Recent Development Table 97. Foodscience corporation Company Information Table 98. Foodscience corporation Business Overview Table 99. Foodscience corporation Dog Pharmaceuticals and Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Foodscience corporation Dog Pharmaceuticals and Supplements Product Portfolio Table 101. Foodscience corporation Recent Development Table 102. Manna Pro Products Company Information Table 103. Manna Pro Products Business Overview Table 104. Manna Pro Products Dog Pharmaceuticals and Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Manna Pro Products Dog Pharmaceuticals and Supplements Product Portfolio Table 106. Manna Pro Products Recent Development Table 107. Ark Naturals Company Information Table 108. Ark Naturals Business Overview Table 109. Ark Naturals Dog Pharmaceuticals and Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Ark Naturals Dog Pharmaceuticals and Supplements Product Portfolio Table 111. Ark Naturals Recent Development Table 112. Blackmores Company Information Table 113. Blackmores Business Overview Table 114. Blackmores Dog Pharmaceuticals and Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Blackmores Dog Pharmaceuticals and Supplements Product Portfolio Table 116. Blackmores Recent Development Table 117. Zesty Paws Company Information Table 118. Zesty Paws Business Overview Table 119. Zesty Paws Dog Pharmaceuticals and Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Zesty Paws Dog Pharmaceuticals and Supplements Product Portfolio Table 121. Zesty Paws Recent Development Table 122. Nuvetlabs Company Information Table 123. Nuvetlabs Business Overview Table 124. Nuvetlabs Dog Pharmaceuticals and Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Nuvetlabs Dog Pharmaceuticals and Supplements Product Portfolio Table 126. Nuvetlabs Recent Development Table 127. Mavlab Company Information Table 128. Mavlab Business Overview Table 129. Mavlab Dog Pharmaceuticals and Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Mavlab Dog Pharmaceuticals and Supplements Product Portfolio Table 131. Mavlab Recent Development Table 132. Vetafarm Company Information Table 133. Vetafarm Business Overview Table 134. Vetafarm Dog Pharmaceuticals and Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Vetafarm Dog Pharmaceuticals and Supplements Product Portfolio Table 136. Vetafarm Recent Development Table 137. Nupro Supplements Company Information Table 138. Nupro Supplements Business Overview Table 139. Nupro Supplements Dog Pharmaceuticals and Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Nupro Supplements Dog Pharmaceuticals and Supplements Product Portfolio Table 141. Nupro Supplements Recent Development Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Dog Pharmaceuticals and Supplements Distributors List Table 145. Dog Pharmaceuticals and Supplements Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Dog Pharmaceuticals and Supplements Product Image Figure 2. Global Dog Pharmaceuticals and Supplements Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dog Pharmaceuticals and Supplements Market Size (2021-2032) & (US$ Million) Figure 4. Global Dog Pharmaceuticals and Supplements Sales (2021-2032) & (k units) Figure 5. Global Dog Pharmaceuticals and Supplements Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Dog Pharmaceuticals and Supplements Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Pharmaceuticals Image Figure 9. Supplements Image Figure 10. Global Dog Pharmaceuticals and Supplements Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Dog Pharmaceuticals and Supplements Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Dog Pharmaceuticals and Supplements Sales Market Share by Type (2021-2032) Figure 13. Global Dog Pharmaceuticals and Supplements Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Dog Pharmaceuticals and Supplements Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Type (2021-2032) Figure 16. Puppy Image Figure 17. Adult Dogs Image Figure 18. Global Dog Pharmaceuticals and Supplements Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Dog Pharmaceuticals and Supplements Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Dog Pharmaceuticals and Supplements Sales Market Share by Application (2021-2032) Figure 21. Global Dog Pharmaceuticals and Supplements Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Dog Pharmaceuticals and Supplements Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Application (2021-2032) Figure 24. North America Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Dog Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032) Figure 26. U.S. Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Dog Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032) Figure 31. Germany Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Dog Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032) Figure 38. China Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Dog Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032) Figure 46. Brazil Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Dog Pharmaceuticals and Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Dog Pharmaceuticals and Supplements Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Dog Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Figure 57. North America Dog Pharmaceuticals and Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Dog Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Figure 59. Europe Dog Pharmaceuticals and Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Dog Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Dog Pharmaceuticals and Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Dog Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Dog Pharmaceuticals and Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Dog Pharmaceuticals and Supplements Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Dog Pharmaceuticals and Supplements Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceuticals
  • Supplements
Applications
  • Puppy
  • Adult Dogs
Companies covered
  • Virbac
  • Zoetis
  • Vetoquinol
  • Nestle Purina
  • NOW Foods
  • Nutramax Laboratories
  • Bayer
  • Foodscience corporation
  • Manna Pro Products
  • Ark Naturals
  • Blackmores
  • Zesty Paws
  • Nuvetlabs
  • Mavlab
  • Vetafarm
  • Nupro Supplements

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dog Pharmaceuticals and Supplements Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dog Pharmaceuticals and Supplements Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Dog Pharmaceuticals and Supplements Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Dog Pharmaceuticals and Supplements Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Dog Pharmaceuticals and Supplements Market Dynamics
  1. 2.1 Dog Pharmaceuticals and Supplements Industry Trends
  2. 2.2 Dog Pharmaceuticals and Supplements Industry Drivers
  3. 2.3 Dog Pharmaceuticals and Supplements Industry Opportunities and Challenges
  4. 2.4 Dog Pharmaceuticals and Supplements Industry Restraints
3 Dog Pharmaceuticals and Supplements Market by Manufacturers
  1. 3.1 Global Dog Pharmaceuticals and Supplements Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Dog Pharmaceuticals and Supplements Sales by Manufacturers (2021-2026)
  3. 3.3 Global Dog Pharmaceuticals and Supplements Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Dog Pharmaceuticals and Supplements Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dog Pharmaceuticals and Supplements Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Dog Pharmaceuticals and Supplements Manufacturers, Product Type & Application
  7. 3.7 Global Dog Pharmaceuticals and Supplements Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dog Pharmaceuticals and Supplements Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dog Pharmaceuticals and Supplements Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dog Pharmaceuticals and Supplements Tier 1, Tier 2, and Tier 3
4 Dog Pharmaceuticals and Supplements Market by Type
  1. 4.1 Dog Pharmaceuticals and Supplements Type Introduction
  2. 4.1.1 Pharmaceuticals
  3. 4.1.2 Supplements
  4. 4.2 Global Dog Pharmaceuticals and Supplements Sales by Type
  5. 4.2.1 Global Dog Pharmaceuticals and Supplements Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dog Pharmaceuticals and Supplements Sales by Type (2021-2032)
  7. 4.2.3 Global Dog Pharmaceuticals and Supplements Sales Market Share by Type (2021-2032)
  8. 4.3 Global Dog Pharmaceuticals and Supplements Revenue by Type
  9. 4.3.1 Global Dog Pharmaceuticals and Supplements Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dog Pharmaceuticals and Supplements Revenue by Type (2021-2032)
  11. 4.3.3 Global Dog Pharmaceuticals and Supplements Revenue Market Share by Type (2021-2032)
5 Dog Pharmaceuticals and Supplements Market by Application
  1. 5.1 Dog Pharmaceuticals and Supplements Application Introduction
  2. 5.1.1 Puppy
  3. 5.1.2 Adult Dogs
  4. 5.2 Global Dog Pharmaceuticals and Supplements Sales by Application
  5. 5.2.1 Global Dog Pharmaceuticals and Supplements Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Dog Pharmaceuticals and Supplements Sales by Application (2021-2032)
  7. 5.2.3 Global Dog Pharmaceuticals and Supplements Sales Market Share by Application (2021-2032)
  8. 5.3 Global Dog Pharmaceuticals and Supplements Revenue by Application
  9. 5.3.1 Global Dog Pharmaceuticals and Supplements Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Dog Pharmaceuticals and Supplements Revenue by Application (2021-2032)
  11. 5.3.3 Global Dog Pharmaceuticals and Supplements Revenue Market Share by Application (2021-2032)
6 Global Dog Pharmaceuticals and Supplements Sales by Region
  1. 6.1 Global Dog Pharmaceuticals and Supplements Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dog Pharmaceuticals and Supplements Sales by Region (2021-2032)
  3. 6.2.1 Global Dog Pharmaceuticals and Supplements Sales by Region (2021-2026)
  4. 6.2.2 Global Dog Pharmaceuticals and Supplements Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dog Pharmaceuticals and Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Dog Pharmaceuticals and Supplements Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Dog Pharmaceuticals and Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Dog Pharmaceuticals and Supplements Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Dog Pharmaceuticals and Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Dog Pharmaceuticals and Supplements Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Dog Pharmaceuticals and Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Dog Pharmaceuticals and Supplements Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Dog Pharmaceuticals and Supplements Revenue by Region
  1. 7.1 Global Dog Pharmaceuticals and Supplements Revenue by Region
  2. 7.1.1 Global Dog Pharmaceuticals and Supplements Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Dog Pharmaceuticals and Supplements Revenue by Region (2021-2026)
  4. 7.1.3 Global Dog Pharmaceuticals and Supplements Revenue by Region (2027-2032)
  5. 7.1.4 Global Dog Pharmaceuticals and Supplements Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Dog Pharmaceuticals and Supplements Revenue (2021-2032)
  8. 7.2.2 North America Dog Pharmaceuticals and Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Dog Pharmaceuticals and Supplements Revenue (2021-2032)
  11. 7.3.2 Europe Dog Pharmaceuticals and Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Dog Pharmaceuticals and Supplements Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Dog Pharmaceuticals and Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Dog Pharmaceuticals and Supplements Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Dog Pharmaceuticals and Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Virbac
  2. 8.1.1 Virbac Company Information
  3. 8.1.2 Virbac Business Overview
  4. 8.1.3 Virbac Dog Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Virbac Dog Pharmaceuticals and Supplements Product Portfolio
  6. 8.1.5 Virbac Recent Developments
  7. 8.2 Zoetis
  8. 8.2.1 Zoetis Company Information
  9. 8.2.2 Zoetis Business Overview
  10. 8.2.3 Zoetis Dog Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Dog Pharmaceuticals and Supplements Product Portfolio
  12. 8.2.5 Zoetis Recent Developments
  13. 8.3 Vetoquinol
  14. 8.3.1 Vetoquinol Company Information
  15. 8.3.2 Vetoquinol Business Overview
  16. 8.3.3 Vetoquinol Dog Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Vetoquinol Dog Pharmaceuticals and Supplements Product Portfolio
  18. 8.3.5 Vetoquinol Recent Developments
  19. 8.4 Nestle Purina
  20. 8.4.1 Nestle Purina Company Information
  21. 8.4.2 Nestle Purina Business Overview
  22. 8.4.3 Nestle Purina Dog Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nestle Purina Dog Pharmaceuticals and Supplements Product Portfolio
  24. 8.4.5 Nestle Purina Recent Developments
  25. 8.5 NOW Foods
  26. 8.5.1 NOW Foods Company Information
  27. 8.5.2 NOW Foods Business Overview
  28. 8.5.3 NOW Foods Dog Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 NOW Foods Dog Pharmaceuticals and Supplements Product Portfolio
  30. 8.5.5 NOW Foods Recent Developments
  31. 8.6 Nutramax Laboratories
  32. 8.6.1 Nutramax Laboratories Company Information
  33. 8.6.2 Nutramax Laboratories Business Overview
  34. 8.6.3 Nutramax Laboratories Dog Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Nutramax Laboratories Dog Pharmaceuticals and Supplements Product Portfolio
  36. 8.6.5 Nutramax Laboratories Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Dog Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Dog Pharmaceuticals and Supplements Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 Foodscience corporation
  44. 8.8.1 Foodscience corporation Company Information
  45. 8.8.2 Foodscience corporation Business Overview
  46. 8.8.3 Foodscience corporation Dog Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Foodscience corporation Dog Pharmaceuticals and Supplements Product Portfolio
  48. 8.8.5 Foodscience corporation Recent Developments
  49. 8.9 Manna Pro Products
  50. 8.9.1 Manna Pro Products Company Information
  51. 8.9.2 Manna Pro Products Business Overview
  52. 8.9.3 Manna Pro Products Dog Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Manna Pro Products Dog Pharmaceuticals and Supplements Product Portfolio
  54. 8.9.5 Manna Pro Products Recent Developments
  55. 8.10 Ark Naturals
  56. 8.10.1 Ark Naturals Company Information
  57. 8.10.2 Ark Naturals Business Overview
  58. 8.10.3 Ark Naturals Dog Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ark Naturals Dog Pharmaceuticals and Supplements Product Portfolio
  60. 8.10.5 Ark Naturals Recent Developments
  61. 8.11 Blackmores
  62. 8.11.1 Blackmores Company Information
  63. 8.11.2 Blackmores Business Overview
  64. 8.11.3 Blackmores Dog Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Blackmores Dog Pharmaceuticals and Supplements Product Portfolio
  66. 8.11.5 Blackmores Recent Developments
  67. 8.12 Zesty Paws
  68. 8.12.1 Zesty Paws Company Information
  69. 8.12.2 Zesty Paws Business Overview
  70. 8.12.3 Zesty Paws Dog Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Zesty Paws Dog Pharmaceuticals and Supplements Product Portfolio
  72. 8.12.5 Zesty Paws Recent Developments
  73. 8.13 Nuvetlabs
  74. 8.13.1 Nuvetlabs Company Information
  75. 8.13.2 Nuvetlabs Business Overview
  76. 8.13.3 Nuvetlabs Dog Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Nuvetlabs Dog Pharmaceuticals and Supplements Product Portfolio
  78. 8.13.5 Nuvetlabs Recent Developments
  79. 8.14 Mavlab
  80. 8.14.1 Mavlab Company Information
  81. 8.14.2 Mavlab Business Overview
  82. 8.14.3 Mavlab Dog Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Mavlab Dog Pharmaceuticals and Supplements Product Portfolio
  84. 8.14.5 Mavlab Recent Developments
  85. 8.15 Vetafarm
  86. 8.15.1 Vetafarm Company Information
  87. 8.15.2 Vetafarm Business Overview
  88. 8.15.3 Vetafarm Dog Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Vetafarm Dog Pharmaceuticals and Supplements Product Portfolio
  90. 8.15.5 Vetafarm Recent Developments
  91. 8.16 Nupro Supplements
  92. 8.16.1 Nupro Supplements Company Information
  93. 8.16.2 Nupro Supplements Business Overview
  94. 8.16.3 Nupro Supplements Dog Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Nupro Supplements Dog Pharmaceuticals and Supplements Product Portfolio
  96. 8.16.5 Nupro Supplements Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dog Pharmaceuticals and Supplements Value Chain Analysis
  2. 9.1.1 Dog Pharmaceuticals and Supplements Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dog Pharmaceuticals and Supplements Production Mode & Process
  6. 9.2 Dog Pharmaceuticals and Supplements Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dog Pharmaceuticals and Supplements Distributors
  9. 9.2.3 Dog Pharmaceuticals and Supplements Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst